Thursday, May 26, 2016 8:25:46 AM
Axcelis Announces Shipment Of First 'Purion EXE' To Leading Foundry In Asia Pacific Region
Axcelis Announces Shipment Of First 'Purion EXE' To Leading Foundry In Asia Pacific Region
Alert
Axcelis Technologies, Inc. (MM) (NASDAQ:ACLS)
Intraday Stock Chart
Today : Thursday 26 May 2016
Click Here for more Axcelis Technologies, Inc. (MM) Charts.
BEVERLY, Mass., May 25, 2016 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of innovative, high-productivity solutions for the semiconductor industry, announced today that it has received its first order for the Purion EXE™, an extended energy range option for its industry leading Purion XE™ high energy implanter. The 200mm Purion EXE will be used to support the production of specialty devices to meet the growing demand in the mobile and IoT markets. The system is scheduled to ship in the second quarter.
Aldeborgh, executive vice president, customer operations, commented, "We're excited to be able to offer customers a new system with the ability to perform ultra-high energy implants, with extremely precise and deep doping profiles, on the industry leading Purion XE platform. The applications for these implants are expanding in the specialty device markets, providing strong opportunities for the Purion XE platform."
Bill Bintz, executive vice president, engineering and marketing, commented, "The Purion platform's common architecture, in conjunction with its LINAC technology, has allowed Axcelis to rapidly expand the capabilities of our high energy product line. As a result, we are able to meet the emerging needs of device manufacturers, while simultaneously delivering exceptional reliability, manufacturing flexibility and capital efficiency. The product line is available in both 200mm and 300mm configurations."
About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 35 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.
http://ih.advfn.com/p.php?pid=nmona&article=71571950&symbol=ACLS
1c
Recent ACLS News
- Axcelis Announces Financial Results for First Quarter 2024 • PR Newswire (US) • 05/01/2024 08:01:00 PM
- AXCELIS WINS THE TEXAS INSTRUMENTS 2023 SUPPLIER EXCELLENCE AWARD • PR Newswire (US) • 04/23/2024 12:00:00 PM
- Axcelis Announces Timing and Availability of First Quarter 2024 Results and Conference Call • PR Newswire (US) • 04/11/2024 12:00:00 PM
- Axcelis Announces Shipment of 'Purion EXE SiC Power Series' Implanter and Successful 'Purion H200 SiC Power Series' Eval Closure at Leading Power Device Manufacturers in Japan • PR Newswire (US) • 04/02/2024 12:00:00 PM
- Axcelis Announces Multiple Shipments of 150mm 'Purion M SiC Power Series' Implanters to Leading Power Device Manufacturers in China • PR Newswire (US) • 03/20/2024 12:00:00 PM
- Axcelis Announces Participation in SEMICON China 2024 • PR Newswire (US) • 03/14/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:15:28 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/08/2024 02:01:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:44:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:36:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:30:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:30:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:30:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:15:26 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 09:45:55 PM
- AXCELIS STRENGTHENS ITS BOARD WITH THE ELECTION OF TWO DIRECTORS • PR Newswire (US) • 02/28/2024 09:01:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/28/2024 08:01:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 01:15:07 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/23/2024 10:19:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 09:10:11 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:18:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:26:29 PM
- Axcelis Announces Financial Results for Fourth Quarter and Full Year 2023 • PR Newswire (US) • 02/07/2024 09:01:00 PM
- Axcelis Announces Participation in Upcoming Investor Conferences • PR Newswire (US) • 01/30/2024 01:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM